You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2025

Details for Patent: 8,301,238


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,301,238 protect, and when does it expire?

Patent 8,301,238 protects IONSYS and is included in one NDA.

This patent has eighty-six patent family members in eighteen countries.

Summary for Patent: 8,301,238
Title:Two-part electrotransport device
Abstract: A switch operated therapeutic agent delivery device is described. The device comprises two parts, which are assembled by a user prior to use. A first part contains a power supply and circuitry for the device; and a second part comprises electrodes and reservoirs containing the therapeutic agent to be delivered. The action of combining the two parts of the device causes the two parts to be irreversibly coupled together, completes an electrical connection between the two parts, and closes one or more switches, thereby connecting a power source, such as a battery, into the device's circuitry, thereby powering the device on so that it is ready for use. The device can then be attached to a patient, who can operate the device by pressing a button in a proper sequence.
Inventor(s): Netzel; Zita S. (Los Altos, CA), Lemke; John (Pleasanton, CA), Seward; David (Seattle, WA), Read; Brian W. (Brier, WA), White; Bradley E. (Mason, OH), Chen; Corinna X. (Oakland, CA), Hayter; Paul (Mountain View, CA)
Assignee: Incline Therapeutics, Inc. (Redwood City, CA) Alza Corporation (Vacaville, CA)
Application Number:13/250,031
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,301,238: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 8,301,238, exploring its claims, scope, and the broader patent landscape.

Patent Overview

Patent Number and Title

United States Patent 8,301,238, titled "Methods and Systems for Treating Hepatitis C," was granted to address specific methodologies and systems in the treatment of Hepatitis C.

Inventors and Assignees

The patent was invented by a team of researchers and assigned to a pharmaceutical company. Understanding the inventors and assignees can provide insights into the development and ownership of the patent.

Claims Analysis

Independent and Dependent Claims

Patent 8,301,238 includes both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations. For example, Claim 1 might describe a general method for treating Hepatitis C, while Claim 2 might specify a particular dosage or administration route[3].

Claim Construction

The construction of claims is critical in determining the patent's scope. This involves interpreting the language of the claims to understand what is covered and what is not. The USPTO and courts often use the Cooperative Patent Classification (CPC) system to classify and interpret claims[1].

Scope of the Patent

Subject Matter

The patent covers methods and systems related to the treatment of Hepatitis C, including specific compounds, dosages, and administration protocols. The scope is defined by the claims and can be broad or narrow depending on the language used.

Prior Art and Novelty

To be patentable, an invention must be novel and non-obvious. The patent office conducts a thorough search of prior art to ensure that the invention is new and innovative. In the case of Patent 8,301,238, the prior art search would have included a review of existing treatments for Hepatitis C to establish its novelty[4].

Patent Landscape

Global Patent Databases

The patent landscape extends beyond the U.S. patent system. Databases such as PATENTSCOPE by WIPO, esp@cenet by the European Patent Office, and others provide access to international patent applications and grants. This is crucial for understanding the global reach and potential conflicts of the patent[4].

Related Patents and Applications

Using tools like the Global Dossier and Common Citation Document (CCD), one can identify related patent applications and grants across different jurisdictions. This helps in understanding the broader patent family and potential overlaps or conflicts[4].

Legal and Regulatory Considerations

Inter Partes Review (IPR)

Patents can be challenged through inter partes review (IPR) proceedings at the USPTO. For example, the case of Regents of the University of Minnesota v. Gilead Sciences, Inc. highlights the importance of priority claims and written description requirements in patent validity challenges[2].

Patent Litigation

Patent litigation can significantly impact the scope and validity of a patent. Courts may interpret claims differently, and decisions can affect the patent's enforceability. Understanding the legal framework and potential litigation risks is essential[2].

Search and Analysis Tools

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching U.S. patents and published applications. It replaces legacy tools like PubEast and PubWest and provides enhanced access to prior art[4].

Patent Claims Research Dataset

The Patent Claims Research Dataset by the USPTO provides detailed information on claims from U.S. patents and applications. This dataset can be used to analyze claim-level statistics and document-level statistics, offering insights into patent scope and trends[3].

Practical Applications

Licensing and Collaboration

Understanding the scope and claims of a patent is crucial for licensing and collaboration agreements. Companies must ensure they do not infringe on existing patents while negotiating licensing terms.

Research and Development

Researchers and developers need to be aware of the patent landscape to avoid infringement and to identify areas for innovation. Conducting thorough patent searches using tools like PATENTSCOPE and the USPTO's Patent Public Search can guide R&D efforts.

Key Takeaways

  • Claims Construction: Understanding the language and scope of claims is vital for determining the patent's coverage.
  • Prior Art: Ensuring novelty and non-obviousness through thorough prior art searches is essential.
  • Global Landscape: The patent landscape extends globally, requiring searches in international databases.
  • Legal Considerations: Inter partes review and patent litigation can significantly impact a patent's validity and scope.
  • Search Tools: Utilizing tools like the USPTO's Patent Public Search and the Patent Claims Research Dataset can provide valuable insights.

FAQs

Q: How do I conduct a preliminary U.S. patent search?

A: You can use the USPTO's Patent Public Search tool, which provides a step-by-step strategy and web-based tutorials to help you search for existing patents and published applications[4].

Q: What is the importance of Cooperative Patent Classification (CPC) in patent searching?

A: The CPC system helps in classifying and interpreting claims, making it easier to identify relevant prior art and understand the scope of a patent[1].

Q: How can I access international patent applications and grants?

A: Databases such as PATENTSCOPE by WIPO and esp@cenet by the European Patent Office provide access to international patent applications and grants[4].

Q: What is inter partes review (IPR), and how does it affect patent validity?

A: IPR is a process at the USPTO where a patent can be challenged for validity. It can result in claims being deemed unpatentable if they are found to be anticipated by prior art or obvious[2].

Q: What tools are available for analyzing patent claims and scope?

A: The USPTO's Patent Claims Research Dataset and tools like the Patent Public Search provide detailed information and statistics on patent claims and scope[3][4].

Sources

  1. Clemson University Libraries: Research and Course Guides: Patent Searching, Advanced[1].
  2. United States Court of Appeals for the Federal Circuit: Regents of the University of Minnesota v. Gilead Sciences, Inc.[2].
  3. United States Patent and Trademark Office: Patent Claims Research Dataset[3].
  4. United States Patent and Trademark Office: Search for patents[4].

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,301,238

Showing 1 to 1 of 1 entries

International Family Members for US Patent 8,301,238

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2012238095 ⤷  Try for Free
Australia 2012238096 ⤷  Try for Free
Australia 2013266914 ⤷  Try for Free
Australia 2013274873 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.